Graft-Versus-Host Disease (GVHD) Market 2028 By Product Type inhibitors, Treatment Type, Distribution Channel and Geography | The Insight Partners

Graft-Versus-Host Disease (GVHD) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Corticosteroids, ATG therapies, IL2R alpha (CD25) inhibitors, TNF alpha inhibitors, Calcineurin inhibitors, MTOR inhibitors, SOT therapies, Anti-neoplastic therapies, Stem Cell Treatments, Extracorporeal Photophoresis, Other biologics); Treatment Type (Prophylaxis GVHD, Chronic GVHD, Acute GVHD); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00006856 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Graft-Versus-Host Disease (GVHD) Market - By Product Type
1.3.2 Graft-Versus-Host Disease (GVHD) Market - By Treatment Type
1.3.3 Graft-Versus-Host Disease (GVHD) Market - By Distribution Channel
1.3.4 Graft-Versus-Host Disease (GVHD) Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GRAFT-VERSUS-HOST DISEASE (GVHD) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. GRAFT-VERSUS-HOST DISEASE (GVHD) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GRAFT-VERSUS-HOST DISEASE (GVHD) MARKET - GLOBAL MARKET ANALYSIS
6.1. GRAFT-VERSUS-HOST DISEASE (GVHD) - GLOBAL MARKET OVERVIEW
6.2. GRAFT-VERSUS-HOST DISEASE (GVHD) - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. GRAFT-VERSUS-HOST DISEASE (GVHD) MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CORTICOSTEROIDS
7.3.1. Overview
7.3.2. Corticosteroids Market Forecast and Analysis
7.4. ATG THERAPIES
7.4.1. Overview
7.4.2. ATG therapies Market Forecast and Analysis
7.5. IL2R ALPHA (CD25) INHIBITORS
7.5.1. Overview
7.5.2. IL2R alpha (CD25) inhibitors Market Forecast and Analysis
7.6. TNF ALPHA INHIBITORS
7.6.1. Overview
7.6.2. TNF alpha inhibitors Market Forecast and Analysis
7.7. CALCINEURIN INHIBITORS
7.7.1. Overview
7.7.2. Calcineurin inhibitors Market Forecast and Analysis
7.8. MTOR INHIBITORS
7.8.1. Overview
7.8.2. mTOR inhibitors Market Forecast and Analysis
7.9. SOT THERAPIES
7.9.1. Overview
7.9.2. SOT therapies Market Forecast and Analysis
7.10. ANTI-NEOPLASTIC THERAPIES
7.10.1. Overview
7.10.2. Anti-neoplastic therapies Market Forecast and Analysis
7.11. STEM CELL TREATMENTS
7.11.1. Overview
7.11.2. Stem Cell Treatments Market Forecast and Analysis
7.12. EXTRACORPOREAL PHOTOPHORESIS
7.12.1. Overview
7.12.2. Extracorporeal Photophoresis Market Forecast and Analysis
7.13. OTHER BIOLOGICS
7.13.1. Overview
7.13.2. Other biologics Market Forecast and Analysis
8. GRAFT-VERSUS-HOST DISEASE (GVHD) MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. PROPHYLAXIS GVHD
8.3.1. Overview
8.3.2. Prophylaxis GVHD Market Forecast and Analysis
8.4. CHRONIC GVHD
8.4.1. Overview
8.4.2. Chronic GVHD Market Forecast and Analysis
8.5. ACUTE GVHD
8.5.1. Overview
8.5.2. Acute GVHD Market Forecast and Analysis
9. GRAFT-VERSUS-HOST DISEASE (GVHD) MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis

10. GRAFT-VERSUS-HOST DISEASE (GVHD) MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Graft-Versus-Host Disease (GVHD) Market Overview
10.1.2 North America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis
10.1.3 North America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Product Type
10.1.4 North America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Treatment Type
10.1.5 North America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Countries
10.1.6.1 United States Graft-Versus-Host Disease (GVHD) Market
10.1.6.1.1 United States Graft-Versus-Host Disease (GVHD) Market by Product Type
10.1.6.1.2 United States Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.1.6.1.3 United States Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.1.6.2 Canada Graft-Versus-Host Disease (GVHD) Market
10.1.6.2.1 Canada Graft-Versus-Host Disease (GVHD) Market by Product Type
10.1.6.2.2 Canada Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.1.6.2.3 Canada Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.1.6.3 Mexico Graft-Versus-Host Disease (GVHD) Market
10.1.6.3.1 Mexico Graft-Versus-Host Disease (GVHD) Market by Product Type
10.1.6.3.2 Mexico Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.1.6.3.3 Mexico Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Graft-Versus-Host Disease (GVHD) Market Overview
10.2.2 Europe Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis
10.2.3 Europe Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Product Type
10.2.4 Europe Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Treatment Type
10.2.5 Europe Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Graft-Versus-Host Disease (GVHD) Market
10.2.6.1.1 Germany Graft-Versus-Host Disease (GVHD) Market by Product Type
10.2.6.1.2 Germany Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.2.6.1.3 Germany Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.2.6.2 France Graft-Versus-Host Disease (GVHD) Market
10.2.6.2.1 France Graft-Versus-Host Disease (GVHD) Market by Product Type
10.2.6.2.2 France Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.2.6.2.3 France Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.2.6.3 Italy Graft-Versus-Host Disease (GVHD) Market
10.2.6.3.1 Italy Graft-Versus-Host Disease (GVHD) Market by Product Type
10.2.6.3.2 Italy Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.2.6.3.3 Italy Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.2.6.4 Spain Graft-Versus-Host Disease (GVHD) Market
10.2.6.4.1 Spain Graft-Versus-Host Disease (GVHD) Market by Product Type
10.2.6.4.2 Spain Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.2.6.4.3 Spain Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.2.6.5 United Kingdom Graft-Versus-Host Disease (GVHD) Market
10.2.6.5.1 United Kingdom Graft-Versus-Host Disease (GVHD) Market by Product Type
10.2.6.5.2 United Kingdom Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.2.6.5.3 United Kingdom Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.2.6.6 Rest of Europe Graft-Versus-Host Disease (GVHD) Market
10.2.6.6.1 Rest of Europe Graft-Versus-Host Disease (GVHD) Market by Product Type
10.2.6.6.2 Rest of Europe Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.2.6.6.3 Rest of Europe Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Graft-Versus-Host Disease (GVHD) Market Overview
10.3.2 Asia-Pacific Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis
10.3.3 Asia-Pacific Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Treatment Type
10.3.5 Asia-Pacific Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Graft-Versus-Host Disease (GVHD) Market
10.3.6.1.1 Australia Graft-Versus-Host Disease (GVHD) Market by Product Type
10.3.6.1.2 Australia Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.3.6.1.3 Australia Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.3.6.2 China Graft-Versus-Host Disease (GVHD) Market
10.3.6.2.1 China Graft-Versus-Host Disease (GVHD) Market by Product Type
10.3.6.2.2 China Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.3.6.2.3 China Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.3.6.3 India Graft-Versus-Host Disease (GVHD) Market
10.3.6.3.1 India Graft-Versus-Host Disease (GVHD) Market by Product Type
10.3.6.3.2 India Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.3.6.3.3 India Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.3.6.4 Japan Graft-Versus-Host Disease (GVHD) Market
10.3.6.4.1 Japan Graft-Versus-Host Disease (GVHD) Market by Product Type
10.3.6.4.2 Japan Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.3.6.4.3 Japan Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.3.6.5 South Korea Graft-Versus-Host Disease (GVHD) Market
10.3.6.5.1 South Korea Graft-Versus-Host Disease (GVHD) Market by Product Type
10.3.6.5.2 South Korea Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.3.6.5.3 South Korea Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Graft-Versus-Host Disease (GVHD) Market
10.3.6.6.1 Rest of Asia-Pacific Graft-Versus-Host Disease (GVHD) Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.3.6.6.3 Rest of Asia-Pacific Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Graft-Versus-Host Disease (GVHD) Market Overview
10.4.2 Middle East and Africa Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis
10.4.3 Middle East and Africa Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Treatment Type
10.4.5 Middle East and Africa Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Graft-Versus-Host Disease (GVHD) Market
10.4.6.1.1 South Africa Graft-Versus-Host Disease (GVHD) Market by Product Type
10.4.6.1.2 South Africa Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.4.6.1.3 South Africa Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.4.6.2 Saudi Arabia Graft-Versus-Host Disease (GVHD) Market
10.4.6.2.1 Saudi Arabia Graft-Versus-Host Disease (GVHD) Market by Product Type
10.4.6.2.2 Saudi Arabia Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.4.6.2.3 Saudi Arabia Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.4.6.3 U.A.E Graft-Versus-Host Disease (GVHD) Market
10.4.6.3.1 U.A.E Graft-Versus-Host Disease (GVHD) Market by Product Type
10.4.6.3.2 U.A.E Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.4.6.3.3 U.A.E Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Graft-Versus-Host Disease (GVHD) Market
10.4.6.4.1 Rest of Middle East and Africa Graft-Versus-Host Disease (GVHD) Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.4.6.4.3 Rest of Middle East and Africa Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Graft-Versus-Host Disease (GVHD) Market Overview
10.5.2 South and Central America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis
10.5.3 South and Central America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Treatment Type
10.5.5 South and Central America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Graft-Versus-Host Disease (GVHD) Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Graft-Versus-Host Disease (GVHD) Market
10.5.6.1.1 Brazil Graft-Versus-Host Disease (GVHD) Market by Product Type
10.5.6.1.2 Brazil Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.5.6.1.3 Brazil Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.5.6.2 Argentina Graft-Versus-Host Disease (GVHD) Market
10.5.6.2.1 Argentina Graft-Versus-Host Disease (GVHD) Market by Product Type
10.5.6.2.2 Argentina Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.5.6.2.3 Argentina Graft-Versus-Host Disease (GVHD) Market by Distribution Channel
10.5.6.3 Rest of South and Central America Graft-Versus-Host Disease (GVHD) Market
10.5.6.3.1 Rest of South and Central America Graft-Versus-Host Disease (GVHD) Market by Product Type
10.5.6.3.2 Rest of South and Central America Graft-Versus-Host Disease (GVHD) Market by Treatment Type
10.5.6.3.3 Rest of South and Central America Graft-Versus-Host Disease (GVHD) Market by Distribution Channel

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. GRAFT-VERSUS-HOST DISEASE (GVHD) MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BRISTOL-MYERS SQUIBB COMPANY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER, INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NEOVII PHARMACEUTICALS AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ABBVIE INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTELLAS PHARMA INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK KGAA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SOLIGENIX
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GENENTECH, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INCYTE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Bristol-Myers Squibb Company
3. Pfizer, Inc
4. Neovii Pharmaceuticals AG
5. AbbVie Inc
6. Astellas Pharma Inc
7. Merck KGaA
8. Soligenix
9. Genentech, Inc
10. Incyte
TIPRE00006856
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount